Jean G. Ford, MD Jean G. Ford, MD Paul J. Johnson Chair, Department of Medicine
Einstein Healthcare Network

Dr. Ford is a physician and scholar whose career began at Harlem Hospital Center, where he served as the Director of the Division of Pulmonary and Critical Care Medicine, and as a faculty member at Columbia University in New York City. Upon joining Johns Hopkins University in 2002, Dr. Ford has served as the Associate Director of Community Programs and Research in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (SKCCC). Currently, he also serves as Director of the Johns Hopkins Center to Reduce Cancer Disparities. He is an Associate Professor in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD. 

Throughout his career, Dr. Ford has been dedicated to understanding health care disparities. His research focuses on applying epidemiologic methods 1) to understand factors that contribute to adverse health outcomes in underserved communities, and 2) to design and evaluate innovative intervention strategies toward eliminating health care disparities in such communities. He directs a multidisciplinary research program at Johns Hopkins University and has received multiple NIH awards as Principal Investigator. 

With the guidance of the Baltimore City Community Health Coalition, Dr. Ford directed the development of community-based programs that conducted extensive outreach and education, and delivered no-cost cancer screening, diagnostic evaluation and treatment services to a low-income, multiethnic population of uninsured and underinsured individuals in Baltimore City. Dr. Ford has also directed the Partnership for Healthy Seniors, the CMS-funded Cancer Prevention and Treatment Demonstration at Johns Hopkins. This consists of two randomized controlled trials (N = 2,800) that evaluate the effects of patient navigation on cancer screening and treatment among African American older adults from Baltimore City. He led a systematic review on the access of underrepresented populations to cancer clinical trials. Currently, he serves as Principal Investigator for the East Region of “Enhancing Minority Participation in Clinical Trials (EMPaCT)”, a NIMHD-funded consortium of five NCI-designated cancer centers that is evaluating strategies to improve minority accrual to clinical trials.